Venous thromboembolism in a case with pemphigus vulgaris after infusion of rituximab plus systemic glucocorticoids and azathioprine: A possible adverse effect of rituximab?

Venous thromboembolism in a case with pemphigus vulgaris after infusion of rituximab plus systemic glucocorticoids and azathioprine: A possible adverse effect of rituximab?

Bibliographic Details
Main Authors:	Kuan-Jou Wu, Kai-Che Wei
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2021-01-01
Series:	Dermatologica Sinica
Online Access:	http://www.dermsinica.org/article.asp?issn=1027-8117;year=2021;volume=39;issue=2;spage=103;epage=104;aulast=Wu

Similar Items

Pre-infusion checklist for rituximab in pemphigus vulgaris patients: clinical audit
by: Farah Sagheer, et al.
Published: (2023-07-01)

Is It Time to Reconsider Rituximab Dosing Regimens for Pemphigus Vulgaris?
by: Christian Ciolfi, et al.
Published: (2024-01-01)

Four cases of recalcitrant pemphigus vulgaris salvaged with rituximab
by: Samyak Ganjre, et al.
Published: (2017-01-01)

Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil
by: Stephanie Del Rio Navarrete Biot, et al.
Published: (2014-12-01)

Rituximab in the Management of a Child with Pemphigus Vulgaris: Case Study
by: Nikolay N. Murashkin, et al.
Published: (2022-11-01)

Role of Rituximab in the Treatment of Pemphigus Vulgaris: Patient Selection and Acceptability
by: Ciolfi C, et al.
Published: (2022-11-01)

Pemphigus vulgaris successfully treated with ocrelizumab following rituximab allergy
by: Gabrielle Benesh, BS, et al.
Published: (2021-10-01)

Rituximab monotherapy in mild pemphigus
by: Ali Nili, et al.
Published: (2022-04-01)

Immunocytometric Analysis of Oral Pemphigus vulgaris Patients after Treatment with Rituximab as Adjuvant
by: Giulio Fortuna, et al.
Published: (2021-11-01)

Use of rituximab in pemphigus vulgaris/foliaceus patients during COVID-19 pandemic
by: Inês Aparício-Martins, et al.
Published: (2022-10-01)

Comparison of rituximab and conventional adjuvant therapy for pemphigus vulgaris: A retrospective analysis.
by: Ashwin Agarwal, et al.
Published: (2018-01-01)

Maintenance therapy with azathioprine prolonged duration of remission for pemphigus patients who received rituximab as first-line or add-on therapy
by: Yung-Tsu Cho, et al.
Published: (2020-01-01)

The efficacy and safety of low-dose rituximab in the treatment of pemphigus vulgaris: a cohort study
by: Xingli Zhou, et al.
Published: (2024-12-01)

Estimating the susceptibility to SARS-CoV-2 infection with rituximab use for pemphigus vulgaris
by: Zainab A. Jafri, et al.
Published: (2022-04-01)

Efficacy and safety of biosimilar rituximab in patients with pemphigus vulgaris: a prospective observational study
by: Roja Toosi, et al.
Published: (2021-01-01)

Pemphigus vulgaris with refractory gingival ulcerations, successfully treated with rituximab—A case report
by: Mateja Dolenc‐Voljč, et al.
Published: (2022-09-01)

Severe Multi-Resistant Pemphigus vulgaris: prolonged remission with a single cycle of Rituximab
by: Isabela Soubhia Corral, et al.
Published: (2013-08-01)

Rituximab Therapy for Treatment of Pemphigus in Southeast Asians
by: Kanokrungsee S, et al.
Published: (2021-04-01)

Rituximab‐induced psoriasis in a patient with pemphigus vulgaris: A case report and literature review
by: Leila Ghadirzade Arani, et al.
Published: (2024-03-01)

COVID-19 in pemphigus vulgaris patients with previous rituximab therapy: a tele-medicine experience
by: Mohammad Shahidi-Dadras, et al.
Published: (2022-02-01)

Management of pemphigus vulgaris with rituximab: A case report and brief review on emerging treatment options
by: Massillamani Francis, et al.
Published: (2019-01-01)

Serum sickness following rituximab therapy in a patient with pemphigus vulgaris: A case report
by: Mohamad Y. Khatib, et al.
Published: (2021-02-01)

Off-label use of rituximab in dermatology: pemphigus treatment
by: Lislaine Bomm, et al.
Published: (2013-08-01)

Severe Pemphigus Vulgaris Resistant to Conventional Therapies and with Hypersensitivity to Rituximab in a 12-Year-Old Child
by: Maria Beatrice De Felici Del Giudice, et al.
Published: (2023-05-01)

Efficacy and safety of biosimilar rituximab in the treatment of pemphigus vulgaris: a single center experience of 12 cases
by: Federico Bardazzi, et al.
Published: (2022-01-01)

Radiation-Associated Pemphigus Vulgaris in a Patient With Preceding Malignancy: Treatment With Rituximab as a Valuable Option
by: Franziska Schauer, et al.
Published: (2020-01-01)

Clinical impact and a prognostic marker of early rituximab treatment after rituximab reimbursement in Korean pemphigus patients
by: Ahreum Song, et al.
Published: (2022-08-01)

How to decrease systemic corticosteroids in pemphigus patients under rituximab
by: Fabrizio Martora, et al.
Published: (2022-07-01)

Real world evidence: Patients with refractory pemphigus treated with Rituximab
by: Vagiani Perifani, et al.
Published: (2021-12-01)

A modified regimen of rituximab in pemphigus: A retrospective study
by: Tanvi Pradeep Vaidya, et al.
Published: (2020-01-01)

A comparative study to evaluate the efficacy and cost of rituximab versus dexamethasone cyclophosphamide pulse in patients of pemphigus vulgaris
by: Sudip Das, et al.
Published: (2021-01-01)

Adverse infusion reactions to rituximab in systemic lupus erythematosus: a retrospective analysis
by: Ashleigh Hennessey, et al.
Published: (2019-08-01)

Sustained CD19+CD27+ Memory B Cell Depletion after Rituximab Treatment in Patients with Pemphigus Vulgaris
by: Katharina Boch, et al.
Published: (2022-03-01)

Infusion reactions to rituximab administration: algorithm of management
by: D.D. Ivanov, et al.
Published: (2022-06-01)

Rituximab treatment of pemphigus in women of childbearing age: experience with two patients
by: Eden P. Lake, et al.
Published: (2017-11-01)

Pregnancy outcomes in women with pemphigus exposed to rituximab before or during pregnancy
by: Azin Dehghanimahmoudabadi, MD, et al.
Published: (2022-10-01)

Successful treatment of recalcitrant juvenile pemphigus foliaceus with intravenous immunoglobulin and rituximab
by: Hock Gin Teo, et al.
Published: (2022-01-01)

The positive impact of rituximab on the quality of life and mental health in patients with pemphigus
by: Hanan Rashid, MD, et al.
Published: (2022-06-01)

Rituximab for the treatment of pemphigus and pemphigoid: A case series of ten patients
by: Safaa S Alwaash, et al.
Published: (2019-01-01)

A comparative effectiveness research of azathioprine and cyclophosphamide on the clinical and serological response in pemphigus vulgaris
by: Kabir Sardana, et al.
Published: (2016-01-01)